• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, August 22, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Researchers develop eco-friendly, 4-in-1 catalyst

Bioengineer by Bioengineer
April 24, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Sun Lab / Seto Lab / Brown University

PROVIDENCE, R.I. [Brown University] –Brown University researchers have developed a new composite catalyst that can perform four separate chemical reactions in sequential order and in one container to produce compounds useful in making a wide range of pharmaceutical products.

"It normally takes multiple catalysts to carry out all of the steps of this reaction," said Chao Yu, a post-doctoral researcher at Brown who co-led the work with graduate student Xuefeng Guo. "But we found a single nanocatalyst that can perform this multistep reaction by itself."

The research, described in the Journal of the American Chemical Society, was a collaboration between the labs of Brown professors Christopher Seto and Shouheng Sun, who are coauthors of the paper.

The work was done, the researchers said, with an eye toward finding ways of making the chemical industry more environmentally sustainable. Multi-reaction catalysts like this one are a step toward that goal.

"If you're running four different reactions separately, then you've got four different steps that require solvents and starting materials, and they each leave behind waste contaminated with byproducts from the reaction," Seto said. "But if you can do it all in one pot, you can use less solvent and reduce waste."

The team made their new catalyst by growing silver-palladium nanoparticles on the surface of nanorods made of oxygen-deficient tungsten-oxide (tungsten-oxide with a few of its oxygen atoms missing). The researchers showed that it could catalyze the series of reactions needed to convert common starting materials formic acid, nitrobenzene and an aldehyde into a benzoxazole, which can be used to make antibacterials, antifungals and NSAID painkillers. The researchers showed that the catalyst could also be used to create another compound, quinazoline, which is used in a variety of anti-cancer drugs.

Experiments showed that the catalyst could perform the four reactions with a nearly quantitative yield — meaning it produces the maximum possible amount of product for a given amount of starting materials. The reactions were performed at a lower temperature, in a shorter amount of time, and using solvents that are more environmentally friendly than those normally used for these reactions.

"The temperature we used to synthesize this product is around 80 degrees Celsius," Guo said. "Normally the reaction happens around 130 degrees and you need to run the reaction for one or two days. But we can get a similar yield at 80 degrees in eight hours."

The new catalyst also is able to make the benzoxazole compounds using starting materials that are more environmentally benign than those generally used. The reaction chain requires a hydrogen source for its initial step. That source could be pure hydrogen gas, which is difficult to store and transport, or it could be extracted from a chemical compound. A compound called ammonia borane is often used for this purpose, but the new catalyst enables formic acid to be used instead, which is "cheaper, greener and less toxic," Yu said.

And while many catalysts tested in these reactions cannot be used more than once without severely damaging their efficiency, the researchers were able to use the new catalyst up to five times with little drop-off in reaction yield.

Sun says that studies like this one represents an emerging line of research in greener chemistry.

"Normally in catalysis we're doing one reaction at a time, with a different catalyst for each reaction" said Shouheng Sun, a professor of chemistry at Brown. "But there's growing interest in coming up with catalysts that can perform multiple reactions in one pot, and that's what we've done here."

###

The work was supported in part by the U.S. Army Research Laboratory and the U.S. Army Research Office (W911NF-15-1-0147).

Media Contact

Kevin Stacey
[email protected]
401-863-3766
@brownuniversity

http://news.brown.edu/

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

B3GNT5 Controls EMT, MET, Chemoresistance Mechanisms

B3GNT5 Controls EMT, MET, Chemoresistance Mechanisms

August 22, 2025
blank

Brain Area 46: The Hub of Emotion Regulation in Marmosets

August 22, 2025

New Insights into the Cumulative HBsAg/HBV DNA Ratio in Immune-Tolerant Hepatitis B Patients

August 22, 2025

Anti-PD-1 Boosts Gastric Cancer with Hepatitis B

August 22, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    Molecules in Focus: Capturing the Timeless Dance of Particles

    141 shares
    Share 56 Tweet 35
  • New Drug Formulation Transforms Intravenous Treatments into Rapid Injections

    114 shares
    Share 46 Tweet 29
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    81 shares
    Share 32 Tweet 20
  • Modified DASH Diet Reduces Blood Sugar Levels in Adults with Type 2 Diabetes, Clinical Trial Finds

    60 shares
    Share 24 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

B3GNT5 Controls EMT, MET, Chemoresistance Mechanisms

Brain Area 46: The Hub of Emotion Regulation in Marmosets

New Insights into the Cumulative HBsAg/HBV DNA Ratio in Immune-Tolerant Hepatitis B Patients

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.